SGLT2 inhibitor empagliflozin could be a new treatment for children with type 2 diabetes: lancet

Published Date: 04 Mar 2023

United States: Empagliflozin could be a new treatment option for children and adolescents with type 2 diabetes, with phase 3 clinical trials showing...

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Global inequalities found in cancer research funding

2.

FDA Approves Treosulfan as Part of AML/MDS Conditioning Regimen

3.

New Clues to Origin of T-Cell Lymphoma After CAR-T Therapy

4.

Congresswoman has cancer; the IRS is suing a controversial doctor; and caffeine and teenagers.

5.

Advanced breast cancer patients living longer thanks to improvements in treatment and care


© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot